Chronic Disease Indicators, 2020 (CDC)
The Chronic Disease Indicators (CDI) is a surveillance report developed by the CDC, the Council of State and Territorial Epidemiologists (CSTE), and the National Association of Chronic Disease Directors (NACDD) to collect standardized data on chronic disease by state.
- In 2020, Arthritis among adults aged 18 years or older in Delaware (22.9%)was higher than the overall US prevalence (22.3%).
- In 2020, the Asthma prevalence among adults aged 18 years or older in Delaware (10.8%) was higher than the overall US prevalence (9.6%)
- The average annual invasive cancer incidence from 2014-2018 in Delaware was 473 cases per 100,000 population; this is significantly higher than the overall US incidence rate of 439.8 cases per 100,000.
- The average annual invasive cancer mortality from 2014-2018 in Delaware was 164.8 per 100,000 deaths; this is higher than the overall US mortality (155.5 per 100,000 deaths).
- In 2019, the mortality rate from any cardiovascular disease was 214.3 per 100,000 deaths in Delaware; this is roughly equal to the overall calculated US cardiovascular mortality (214.6 per 100,000 deaths).
- In 2019, the mortality rate from stroke was 45.1 per 100,000 deaths in Delaware; this is higher than the overall US stroke mortality rate (37 per 100,000 deaths).
- In 2019, the high cholesterol prevalence in adults 18 years and older in Delaware (30.1%) was higher than the overall US high cholesterol prevalence (29.1%)
- In 2019, the end-stage renal disease mortality rate was 54.7 per 100,000 deaths in Delaware; this was slightly lower than the US end-stage renal disease mortality rate (56.5 per 100,000 deaths).
- In 2020, the prevalence of chronic kidney disease in Delaware (2.9%) was higher than the US chronic kidney disease prevalence (2.6%).
- In 2019, the mortality rate with COPD as an underlying or contributing cause among adults ages 45 and greater was 97.6 per 100,000 deaths in Delaware; This was lower than the US COPD mortality rate (213.2 per 100,000 deaths).
- In 2020, the prevalence of COPD among adults 18 and older in Delaware (5.2%) was lower than the US COPD prevalence (5.6%)
- In 2019, the mortality rate due to diabetes was 50.2 per 100,000 deaths in Delaware; This was lower than the US diabetes mortality rate (69.3 per 100,000 deaths)
- In 2020, the prevalence of diagnosed diabetes among adults 18 and older in Delaware (10.5%) was higher than the overall US prevalence of diabetes (9.4%)
* All rates and proportions are age-standardized
Behavioral Risk Factor Survey, 2017 (BRFS)
In 2017, the Behavioral Risk Factor Survey (BRFS) found that hypertension (34.9%) and high cholesterol (34.6%) were the most prevalent chronic diseases in the State of Delaware, affecting nearly one third of Delaware’s population.
Other reports from the BRFS include:
- Arthritis. About one-quarter of the adult population reported being diagnosed with arthritis.
- Asthma. About 15.8% have been told they had asthma (10.6% of the population had asthma in 2017). Women were more affected than men.
- Cancer. About 6.9% of Delaware adults stated they had been diagnosed with skin cancer, and 7.7% said they had another kind of cancer.
- Depression. 19.7% of Delaware adults have been diagnosed with a depressive disorder.
- Heart Disease. 6.4% of adults said they had been diagnosed with coronary heart disease, or had had a heart attack.
- Kidney Disease. More than 3% of adult Delawareans reported being diagnosed with kidney disease at some time.
- Stroke. In 2017, 3.4% of adults in Delaware reported having a stroke.
Reported Cases of Chronic Disease, 2003 (Delaware TODAY)
According to Delaware TODAY, there were nearly 480,000 cases of cancers, diabetes, heart disease, hypertension, stroke, mental disorders and pulmonary conditions reported in the first state in 2003. These conditions “shorten lives, reduce quality of life, and create caregiver burden.”